• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自适应尺寸进化的 MOFs-in-MOF 纳米载体用于增强核靶向肿瘤化疗。

Adaptive Size Evolution of an MOFs-in-MOF Nanovehicle for Enhanced Nucleus-Targeted Tumor Chemotherapy.

机构信息

Collaborative Innovation Center of Biomedical Functional Materials of Jiangsu Province, School of Chemistry and Materials Science, Nanjing Normal University, Nanjing 210023, China.

School of Chemistry and Molecular Engineering, Nanjing Tech University, Nanjing 211816, China.

出版信息

Nano Lett. 2024 Aug 28;24(34):10605-10613. doi: 10.1021/acs.nanolett.4c02817. Epub 2024 Aug 15.

DOI:10.1021/acs.nanolett.4c02817
PMID:39145462
Abstract

A metal-organic frameworks (MOFs)-in-MOF nanovehicle (160 nm), which was constructed with newly prepared ultrasmall Cu(I)Cu(II)-BTC MOFs (UCMs, 2.95 nm) loaded with doxorubicin (DOX) and a nuclear localization signal (NLS) peptide as multicores (UCMDNs) and ZIF-8 as the shell MOF, was proposed to cross layers of biological barriers with adaptive size evolution capacity for achieving efficient nucleus-targeted drug delivery. It first enhanced tumor tissue penetration through its larger nanosize effect. Then the acidic tumor environment made the ZIF-8 shell degrade, releasing small-sized UCMDNs to enter into the cell and into the nucleus under the guidance of NLS. Furthermore, due to the distinct surface structural characteristics of UCMs, UCMDNs remained stable in the cytoplasm and collapsed in the nucleus due to the DOX-DNA interaction to deliver DOX precisely. It showed superior performance in the nucleus-directed delivery of DOX (delivery efficiency up to 56.7%) and a high tumor growth inhibition rate (96.4%), offering promising prospects in tumor chemotherapy.

摘要

一种金属-有机骨架(MOFs)-在-MOF 纳米载体(160nm),由新制备的超小的 Cu(I)Cu(II)-BTC MOFs(UCMs,2.95nm)负载阿霉素(DOX)和核定位信号(NLS)肽作为多核(UCMDNs)和 ZIF-8 作为壳 MOF 构建而成,具有自适应尺寸演变能力,可穿越生物屏障层,实现高效的核靶向药物传递。它首先通过更大的纳米尺寸效应增强肿瘤组织穿透性。然后,酸性肿瘤环境使 ZIF-8 壳降解,在 NLS 的引导下,释放出小尺寸的 UCMDNs 进入细胞并进入细胞核。此外,由于 UCMs 的独特表面结构特征,UCMDNs 在细胞质中保持稳定,而在核内由于 DOX-DNA 相互作用而崩溃,从而精确传递 DOX。它在 DOX 的核定向传递中表现出优异的性能(传递效率高达 56.7%)和高肿瘤生长抑制率(96.4%),为肿瘤化疗提供了有前途的前景。

相似文献

1
Adaptive Size Evolution of an MOFs-in-MOF Nanovehicle for Enhanced Nucleus-Targeted Tumor Chemotherapy.自适应尺寸进化的 MOFs-in-MOF 纳米载体用于增强核靶向肿瘤化疗。
Nano Lett. 2024 Aug 28;24(34):10605-10613. doi: 10.1021/acs.nanolett.4c02817. Epub 2024 Aug 15.
2
Formation and evaluation of doxorubicin and cromoglycate metal-organic framework for anti-cancer activity.用于抗癌活性的阿霉素和色甘酸金属有机框架的形成与评价
Nanomedicine (Lond). 2025 Mar;20(5):467-479. doi: 10.1080/17435889.2025.2459059. Epub 2025 Jan 31.
3
An Enzyme-responsive Porphyrin Metal-organic Framework Nanosystem for Targeted and Enhanced Synergistic Cancer Photo-chemo Therapy.一种用于靶向和增强协同癌症光化学疗法的酶响应性卟啉金属有机框架纳米系统。
Curr Drug Deliv. 2024 Feb 27. doi: 10.2174/0115672018286563240223072702.
4
Improving Chemotherapy Effectiveness: Utilizing CuS Nanoparticles Coated with AS1411 Aptamer and Chitosan for Targeted Delivery of Doxorubicin to Cancerous Cells.提高化疗效果:利用 AS1411 适体和壳聚糖包覆的 CuS 纳米粒子将阿霉素靶向递送至癌细胞。
J Pharm Sci. 2024 Jul;113(7):1865-1873. doi: 10.1016/j.xphs.2024.02.005. Epub 2024 Feb 10.
5
Using Metal-Organic Framework Nanoparticles for Targeted Codelivery of Bortezomib and Iron Ions to Mitochondrial TOM20 to Induce Ferroptosis for Colorectal Cancer Treatment.利用金属有机框架纳米颗粒将硼替佐米和铁离子靶向共递送至线粒体TOM20以诱导铁死亡用于结直肠癌治疗
Mol Pharm. 2025 Aug 4;22(8):4865-4878. doi: 10.1021/acs.molpharmaceut.5c00489. Epub 2025 Jul 17.
6
Combination of Chemical and Physical Cancer Therapeutics Developed with Microcapsules Made of κ-Casein and Gold Nanoparticles in the Presence of Drug-Loaded Phase Change Materials.在载药相变材料存在的情况下,利用由κ-酪蛋白和金纳米颗粒制成的微胶囊开发化学与物理癌症治疗方法的组合。
ACS Appl Mater Interfaces. 2024 May 8;16(18):22924-22933. doi: 10.1021/acsami.4c02185. Epub 2024 Apr 25.
7
Light-Induced Redox-Responsive Smart Drug Delivery System by Using Selenium-Containing Polymer@MOF Shell/Core Nanocomposite.基于含硒聚合物@MOF 壳核纳米复合材料的光响应型智能药物递送系统。
Adv Healthc Mater. 2019 Aug;8(15):e1900406. doi: 10.1002/adhm.201900406. Epub 2019 Jun 11.
8
Competitive coordination assembly of light-degradable gold nanocluster-intercalated metal organic frameworks for photoresponsive drug release.光降解金纳米簇插层金属有机骨架的竞争性配位组装用于光响应药物释放。
J Mater Chem B. 2024 Apr 24;12(16):4018-4028. doi: 10.1039/d3tb03012a.
9
A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents.一种强效多功能 ZIF-8 纳米平台,通过三重递呈化疗/放疗/靶向治疗药物用于结直肠癌治疗。
J Mater Chem B. 2024 Jan 24;12(4):1096-1114. doi: 10.1039/d3tb02571c.
10
Bovine serum albumin-coated ZIF-8 nanoparticles to enhance antitumor and antimetastatic activity of methotrexate: and study.牛血清白蛋白包覆的 ZIF-8 纳米粒子增强甲氨蝶呤的抗肿瘤和抗转移活性:体内研究。
J Biomater Sci Polym Ed. 2024 Oct;35(15):2294-2314. doi: 10.1080/09205063.2024.2379652. Epub 2024 Jul 22.

引用本文的文献

1
Novel Peptide-Modified Zeolitic Imidazolate Framework-8 Nanoparticles with pH-Sensitive Release of Doxorubicin for Targeted Treatment of Colorectal Cancer.新型肽修饰的沸石咪唑酯骨架-8纳米颗粒,具有阿霉素pH敏感释放特性,用于结直肠癌的靶向治疗。
Pharmaceutics. 2025 Feb 13;17(2):246. doi: 10.3390/pharmaceutics17020246.
2
Nanotechnology in healthcare, and its safety and environmental risks.纳米技术在医疗保健中的应用,及其安全性和环境风险。
J Nanobiotechnology. 2024 Nov 15;22(1):715. doi: 10.1186/s12951-024-02901-x.